Sales of macrolides, lincosamides, streptogramins, and amoxicillin/clavulanate in the in- and outpatient setting in 10 European countries, 2007-2010
Ferrer, Pili (Fundació Institut Català de Farmacologia)
Sabaté, Mònica (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Ballarín, Elena (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Fortuny, Joan (RTI Health Solutions)
Rottenkolber, Marietta (Diabetes Research Group, Medical Department 4, University Hospital Munich, Campus Innenstadt, Ludwig-Maximilians-Universität, Ziemssenstr 1)
Schmiedl, Sven (Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten-Herdecke University, Alfred Herrhausen-Strasse 50)
Laporte Rosselló, Joan-Ramón (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Ibáñez, Luisa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Fundació Institut Català de Farmacologia

Date:	2015
Abstract:	The online version of this article (doi:10. 1186/s40064-015-1398-4) contains supplementary material, which is available to authorized users.
Note:	The research leading to these results was conducted as part of the PROTECT Consortium (Pharmacoepidemiological Research on Outcomes of Thera-peutics by a European ConsorTium, http://www.imi-protect.eu) which is apublic-private partnership coordinated by the European Medicines Agency.The PROTECT project has received support from the Innovative Medicines Initiative Join Undertaking [IMIJU] (http://www.imi.europa.eu) under Grant Agreement no 115004, resources of which arecomposed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries andAssociations (EFPIA)companies'in kind contribution. The views expressed are those of the authors only.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Drug utilisation ; Cross-national comparison ; Defined daily doses ; Prescription rates ; Antibacterials ; Hospital ; Ambulatory ; Indication
Published in:	SpringerPlus, Vol. 4 (october 2015) , ISSN 2193-1801

DOI: 10.1186/s40064-015-1398-4
PMID: 26543747

9 p, 3.3 MB

The record appears in these collections:
Articles > Research articles
Articles > Published articles